|
|
Conditioning Regimens |
| Thiotepa, busulfan and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced chronic myelogenous leukemia |
977 |
| D Przepiorka,
I Khouri,
P Thall,
R Mehra,
M-S Lee,
C Ippoliti,
S Giralt,
J Gajewski,
K van Besien,
B Andersson,
M Körbling,
AB Deisseroth & R Champlin
|
|
Abstract
Full Article (PDF)
|
|
Cytokines And Growth Factors |
| Influence of recombinant human granulocyte colony-stimulating factor (filgrastim) on hematopoietic recovery and outcome following allogeneic bone marrow transplantation (BMT) from volunteer unrelated donors |
983 |
| C Berger,
H Bertz,
C Schmoor,
D Behringer,
K Potthoff,
R Mertelsmann & J Finke
|
|
Abstract
Full Article (PDF)
|
|
| A prospective study of G-CSF effects on hemostasis in allogeneic blood stem cell donors |
991 |
| R LeBlanc,
J Roy,
C Demers,
L Vu & G Cantin
|
|
Abstract
Full Article (PDF)
|
|
Myelodysplasia |
| Diagnosis of secondary myelodysplastic syndromes (MDS) following autologous transplantation should not be based only on morphological criteria used for diagnosis of de novo MDS |
997 |
| ML Amigo,
MC del Cañizo,
A Rios,
MA Garcia,
MD Caballero,
A Martin,
N Bermejo,
P Vilches & JF San Miguel
|
|
Abstract
Full Article (PDF)
|
|
Myeloma |
| Melphalan 220 mg/m2 followed by peripheral blood stem cell transplantation in 27 patients with advanced multiple myeloma |
1003 |
| P Moreau,
N Milpied,
B Mahé,
N Juge-Morineau,
M-J Rapp,
R Bataille & J-L Harousseau
|
|
Abstract
Full Article (PDF)
|
|
Graft-Versus-Host Disease |
| Pilocarpine hydrochloride relieves xerostomia in chronic graft-versus-host disease: a sialometrical study |
1007 |
| RM Nagler & A Nagler
|
|
Abstract
Full Article (PDF)
|
|
| Expression of T cell activation antigen CD134 (OX40) has no predictive value for the occurrence or response to therapy of acute graft-versus-host disease in partial T cell-depleted bone marrow transplantation |
1013 |
| APA Gadisseur,
JW Gratama,
C Lamers,
JWJ van Esser,
RLH Bolhuis & JJ Cornelissen
|
|
Abstract
Full Article (PDF)
|
|
Tumour Cell Contamination |
| Analysis of circulating tumor cells in patients with multiple myeloma during the course of high-dose therapy with peripheral blood stem cell transplantation |
1019 |
| K Kiel,
FW Cremer,
C Rottenburger,
C Kallmeyer,
E Ehrbrecht,
A Atzberger,
U Hegenbart,
H Goldschmidt & M Moos
|
|
Abstract
Full Article (PDF)
|
|
Myeloid Reconstitution |
| Long-lasting decrease of marrow and circulating long-term culture initiating cells after allogeneic bone marrow transplant |
1029 |
| C Selleri,
JP Maciejewski,
G De Rosa,
A Raiola,
AM Risitano,
M Picardi,
L Pezzullo,
L Luciano,
P Ricci,
G Varriale,
P Della Cioppa,
L Del Vecchio & B Rotoli
|
|
Abstract
Full Article (PDF)
|
|
Infections Post Transplant |
| Incidence and outcome of Clostridium difficile infection following autologous peripheral blood stem cell transplantation |
1039 |
| S Bilgrami,
JM Feingold,
D Dorsky,
RL Edwards,
RD Bona,
AM Khan,
F Rodriguez-Pinero,
J Clive & PJ Tutschka
|
|
Abstract
Full Article (PDF)
|
|
Growth Post Transplant |
| Nutritional status and growth after bone marrow transplantation (BMT) during childhood: EBMT Late-Effects Working Party retrospective data |
1043 |
| A Cohen,
T Duell,
G Socié,
MT van Lint,
M Weiss,
A Tichelli,
A Rovelli,
JF Apperley,
P Ljungman,
HJ Kolb & on behalf of the EBMT Late-Effects Working Party
|
|
Abstract
Full Article (PDF)
|
|
Quality Of Life |
| Organ toxicity and quality of life after allogeneic bone marrow transplantation in pediatric patients: a single centre retrospective analysis |
1049 |
| S Matthes-Martin,
M Lamche,
R Ladenstein,
W Emminger,
C Felsberger,
R Topf,
H Gadner & C Peters
|
|
Abstract
Full Article (PDF)
|
|
Chimerism |
| Rapid quantification of mixed chimerism using multiplex amplification of short tandem repeat markers and fluorescence detection |
1055 |
| C Thiede,
M Florek,
M Bornhäuser,
M Ritter,
B Mohr,
C Brendel,
G Ehninger & A Neubauer
|
|
Abstract
Full Article (PDF)
|
|
Technical Reports |
| Counterflow centrifugation allows addition of appropriate numbers of T cells to allogeneic marrow and blood stem cell grafts to prevent severe GVHD without substantial loss of mature and immature progenitor cells |
1061 |
| FWMB Preijers,
PB van Hennik,
A Schattenberg,
P Ruijs,
RE Ploemacher & Th de Witte
|
|
Abstract
Full Article (PDF)
|
|
| Selective removal of alloreactive cells from haematopoietic stem cell grafts: graft engineering for GVHD prophylaxis |
1071 |
| MBC Koh,
HG Prentice & MW Lowdell
|
|
Abstract
Full Article (PDF)
|
|
Case Reports |
| Successful bone marrow transplantation in a child with X-linked hyper-IgM syndrome |
1081 |
| T Kato,
I Tsuge,
J Inaba,
K Kato,
T Matsuyama & S Kojima
|
|
Abstract
Full Article (PDF)
|
|
| Successful one antigen mismatched bone marrow transplant for chronic myeloid leukemia (CML) after two failed syngeneic transplants |
1085 |
| A Manna,
A Bacigalupo,
G Palazzo,
B Amurri,
A Maggi & P Mazza
|
|
Abstract
Full Article (PDF)
|
|
| Concurrent Pneumocystis carinii and cytomegalovirus pneumonia after autologous peripheral blood stem cell transplantation |
1087 |
| WM Chuu,
JP Catlett,
DJ Perry,
LG Geddes,
PD Levit,
CS Levy,
MK Buick & V Malkovska
|
|
Abstract
Full Article (PDF)
|
|
| Adoptive autoimmune hyperthyroidism following allogeneic stem cell transplantation from an HLA-identical sibling with Graves’ disease |
1091 |
| GA Berisso,
MT van Lint,
A Bacigalupo & AM Marmont
|
|
Abstract
Full Article (PDF)
|
|
| Allogeneic peripheral blood stem cell transplantation for hypereosinophilic syndrome with severe cardiac dysfunction |
1093 |
| A Chockalingam,
A Jalil,
RK Shadduck & J Lister
|
|
Abstract
Full Article (PDF)
|
|
